Ultimovacs ASA (OSL: ULTI)
Norway
· Delayed Price · Currency is NOK 2.270
+0.070 (3.18%)
Nov 21, 2024, 4:25 PM CET
Ultimovacs ASA Market Cap
Ultimovacs ASA has a market cap or net worth of 75.69 million as of November 21, 2024. Its market cap has decreased by -97.65% in one year.
Market Cap
75.69M
Enterprise Value
-52.75M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.27
Market Cap Chart
Since June 3, 2019, Ultimovacs ASA's market cap has decreased from 863.67M to 75.69M, a decrease of -91.24%. That is a compound annual growth rate of -35.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 75.69M | -98.21% |
| Dec 29, 2023 | 4.23B | 11.67% |
| Dec 30, 2022 | 3.78B | -1.98% |
| Dec 30, 2021 | 3.86B | 50.91% |
| Dec 30, 2020 | 2.56B | 134.21% |
| Dec 30, 2019 | 1.09B | 26.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nordhealth AS | 2.96B |
| Medistim ASA | 2.55B |
| Carasent ASA | 1.45B |
| Photocure ASA | 1.34B |
| Nykode Therapeutics AS | 898.00M |
| ArcticZymes Technologies ASA | 673.12M |
| Gentian Diagnostics ASA | 635.40M |
| Thor Medical ASA | 554.27M |